Auna S.A. (AUNA) stock analysis
Close on Nov 11, 2026
StockData Score
Prices as of Nov 11, 2026How the score works
Weak5 of 30 checks passed
Auna passes 5 of the 30 checks behind our score; 17 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 1/6
- Past performance
- 3/6
- Financial health
- 1/6
- Dividend
- 0/6
What stands out
Revenue growing 10%+ a year
Revenue grew 21.4% a year over the last three fiscal years.
Return on equity above the industry
Auna's return on equity of 6.3% is above the Health Services median of 4.6%.
Net margin above its 5-year average
Net margin was 2.2% over the last twelve months, against a 5-year average of -1.3%.
Net margin above the industry
Auna's net margin of 2.2% is above the Health Services median of -6.3%.
What to watch
Return on equity under 15%
Return on equity was 6.3% over the last twelve months and averaged -3.6% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 7.2%, below the 10% that usually covers the cost of capital.
High debt
Debt is 221% of shareholders' equity, above the 40% we consider low.
Interest not well covered
Operating income covers interest expense 1.0 times; we look for at least 5.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth1/6
Revenue growing 10%+ a year
Revenue grew 21.4% a year over the last three fiscal years.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew -0.0% over the last twelve months; the Health Services median is -0.0%.
Guidance issued
The latest outlook (Fiscal Year 2026 revenue growth, Mar 10, 2026) was issued for the first time, so it neither adds nor takes away points.
Gross margin slipping
Gross margin was 37.9% over the last twelve months, against 39.3% a year earlier.
Past performance3/6
Return on equity under 15%
Return on equity was 6.3% over the last twelve months and averaged -3.6% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 7.2%, below the 10% that usually covers the cost of capital.
Return on equity above the industry
Auna's return on equity of 6.3% is above the Health Services median of 4.6%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin above its 5-year average
Net margin was 2.2% over the last twelve months, against a 5-year average of -1.3%.
Net margin above the industry
Auna's net margin of 2.2% is above the Health Services median of -6.3%.
Financial health1/6
High debt
Debt is 221% of shareholders' equity, above the 40% we consider low.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt not well covered by cash flow
Operating cash flow over the last twelve months equals 18.8% of total debt; we look for at least 20%.
Interest not well covered
Operating income covers interest expense 1.0 times; we look for at least 5.
Short-term assets cover short-term debts
Current assets are 1.11 times current liabilities.
Bankruptcy risk (Altman Z)
Needs market value, working capital and retained earnings.
Dividend0/6
No dividend
Auna has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for Auna. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
High risk
- Average value traded per day
- $930.93K
- Value traded per 1% price move
- $480.12K
Downside
Medium risk
- Typical loss in a bad month
- 16.7%
- Volatility (annualized)
- 44%
- Sharpe ratio, 1 year
- -0.32
- Beta to the S&P 500 (5Y)
- 0.66
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2021 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -0.0% | +21.4% | – | – | |
| Gross profit | -3.6% | +23.7% | – | – | |
| Operating income | -20.2% | +34.9% | – | – | |
| Net income | -11.5% | – | – | – | |
| EPS, diluted | -19.0% | – | – | – | |
| Free cash flow | -0.2% | +112.4% | – | – |
Returns and balance sheet
5 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2021 | FY2021 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | 6.3% | |
| Return on assets | – | – | 1.4% | |
| Current ratio | – | – | 1.11 | |
| Debt to equity | – | – | 2.21 | |
| Net debt to EBITDA | – | – | 3.77× | |
| Interest coverage | – | – | 1.0× | |
| Inventory turnover | – | – | 17.6× | |
| Capex to revenue | – | – | 2.0% | |
| Diluted shares | – | – | 74M |
Cash use needs five years of cash flow figures
Auna does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 2.2% | 0.61× | 4.67× | 6.3% |
| FY2024 | 2.5% | 0.59× | 5.02× | 7.5% |
| FY2023 | -6.6% | 0.54× | 5.64× | -20.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero97.61M PEN
- Cash generatingOperating cash flow above zero662.50M PEN
- Return on assets improvedROA up on the prior year1.4% → 1.4%
- Earnings backed by cashOperating cash flow above net income662.50M PEN vs 97.61M PEN
- Less leverageLong-term debt to assets fell41.9% → 44.1%
- Better liquidityCurrent ratio rose0.88 → 1.11
- No dilutionShare count did not rise68M → 74M
- Gross margin improvedGross margin up on the prior year39.34% → 37.94%
- More efficientAsset turnover rose0.57 → 0.62
See a number that looks wrong?